학술논문

GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone‐sensitive prostate cancer; KYUCOG‐1401.
Document Type
Article
Source
International Journal of Urology; Apr2024, Vol. 31 Issue 4, p362-369, 8p
Subject
GONADOTROPIN releasing hormone
PROSTATE cancer
PROGRESSION-free survival
OVERALL survival
TREATMENT failure
Language
ISSN
09198172
Abstract
Copyright of International Journal of Urology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)